FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2611376475> ?p ?o ?g. }

• W2611376475 endingPage "750" @default.
• W2611376475 startingPage "741" @default.
• W2611376475 abstract "Endothelin-1 (ET-1) is the most potent vasoconstrictor, and is involved in the renal regulation of salt and water homeostasis. When produced in excess in the kidney, ET-1 promotes proteinuria and tubulointerstitial injury. There is great interest in the clinical use of endothelin receptor antagonists (ERAs) in chronic kidney disease (CKD), mainly in diabetic nephropathy (DN). Areas covered: Physiopathological actions of ET-1 on the kidney. Both dual ETAR/ETBR (bosentan) or ETAR specific endothelin antagonists (avosentan and atrasentan, among others), which have progressed to early clinical development, with particular emphasis on atrasentan. Expert opinion: Different phase I and II clinical trials with ERAs in DN, mostly with atrasentan, have shown that these drugs have a marked anti-proteinuric effect on residual proteinuria when administered as add-on therapy in addition to ACEi or ARAII treatment. In the past few years, a series of randomized controlled trials investigating new approaches to DN have provided negative or inconclusive data, or even were terminated due to safety concerns or lack of efficacy. Therefore, we eagerly but cautiously await the results of the ongoing SONAR trial with atrasentan in more than 4,000 patients including assessment of renal and cardiovascular hard-end points (estimated primary completion date, July 2018)." @default.
• W2611376475 created "2017-05-12" @default.
• W2611376475 creator A5003545733 @default.
• W2611376475 creator A5004769237 @default.
• W2611376475 creator A5005804630 @default.
• W2611376475 creator A5018160190 @default.
• W2611376475 creator A5045038056 @default.
• W2611376475 creator A5063479125 @default.
• W2611376475 creator A5077938665 @default.
• W2611376475 date "2017-05-19" @default.
• W2611376475 modified "2023-10-18" @default.
• W2611376475 title "Atrasentan for the treatment of diabetic nephropathy" @default.
• W2611376475 cites W1520693724 @default.
• W2611376475 cites W1541055912 @default.
• W2611376475 cites W1564596764 @default.
• W2611376475 cites W1579732520 @default.
• W2611376475 cites W1758102247 @default.
• W2611376475 cites W1811166049 @default.
• W2611376475 cites W1963095561 @default.
• W2611376475 cites W1972952910 @default.
• W2611376475 cites W1980399901 @default.
• W2611376475 cites W1982639695 @default.
• W2611376475 cites W1990938332 @default.
• W2611376475 cites W1993929076 @default.
• W2611376475 cites W2005872010 @default.
• W2611376475 cites W2008944073 @default.
• W2611376475 cites W2011140067 @default.
• W2611376475 cites W2015170224 @default.
• W2611376475 cites W2020267609 @default.
• W2611376475 cites W2032661901 @default.
• W2611376475 cites W2044597785 @default.
• W2611376475 cites W2048376460 @default.
• W2611376475 cites W2049862929 @default.
• W2611376475 cites W2057928404 @default.
• W2611376475 cites W2059046093 @default.
• W2611376475 cites W2059130506 @default.
• W2611376475 cites W2063013576 @default.
• W2611376475 cites W2065697598 @default.
• W2611376475 cites W2081827693 @default.
• W2611376475 cites W2082723329 @default.
• W2611376475 cites W2084144472 @default.
• W2611376475 cites W2089934320 @default.
• W2611376475 cites W2095224095 @default.
• W2611376475 cites W2096179755 @default.
• W2611376475 cites W2098539467 @default.
• W2611376475 cites W2098892140 @default.
• W2611376475 cites W2099963452 @default.
• W2611376475 cites W2100732774 @default.
• W2611376475 cites W2102373460 @default.
• W2611376475 cites W2105790451 @default.
• W2611376475 cites W2107550750 @default.
• W2611376475 cites W2110051876 @default.
• W2611376475 cites W2120452308 @default.
• W2611376475 cites W2134734822 @default.
• W2611376475 cites W2137247821 @default.
• W2611376475 cites W2142522073 @default.
• W2611376475 cites W2143078493 @default.
• W2611376475 cites W2151541980 @default.
• W2611376475 cites W2153933777 @default.
• W2611376475 cites W2156753852 @default.
• W2611376475 cites W2162804111 @default.
• W2611376475 cites W2229966636 @default.
• W2611376475 cites W2293927871 @default.
• W2611376475 cites W2309649143 @default.
• W2611376475 cites W2311226532 @default.
• W2611376475 cites W2316753212 @default.
• W2611376475 cites W2331135319 @default.
• W2611376475 cites W2334955683 @default.
• W2611376475 cites W2345234619 @default.
• W2611376475 cites W2406000216 @default.
• W2611376475 cites W2409073940 @default.
• W2611376475 cites W2417000216 @default.
• W2611376475 cites W4210343616 @default.
• W2611376475 cites W4240392955 @default.
• W2611376475 cites W4242364069 @default.
• W2611376475 cites W599211393 @default.
• W2611376475 cites W624824473 @default.
• W2611376475 doi "https://doi.org/10.1080/13543784.2017.1325872" @default.
• W2611376475 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28468519" @default.
• W2611376475 hasPublicationYear "2017" @default.
• W2611376475 type Work @default.
• W2611376475 sameAs 2611376475 @default.
• W2611376475 citedByCount "31" @default.
• W2611376475 countsByYear W26113764752018 @default.
• W2611376475 countsByYear W26113764752019 @default.
• W2611376475 countsByYear W26113764752020 @default.
• W2611376475 countsByYear W26113764752021 @default.
• W2611376475 countsByYear W26113764752022 @default.
• W2611376475 countsByYear W26113764752023 @default.
• W2611376475 crossrefType "journal-article" @default.
• W2611376475 hasAuthorship W2611376475A5003545733 @default.
• W2611376475 hasAuthorship W2611376475A5004769237 @default.
• W2611376475 hasAuthorship W2611376475A5005804630 @default.
• W2611376475 hasAuthorship W2611376475A5018160190 @default.
• W2611376475 hasAuthorship W2611376475A5045038056 @default.
• W2611376475 hasAuthorship W2611376475A5063479125 @default.
• W2611376475 hasAuthorship W2611376475A5077938665 @default.
• W2611376475 hasConcept C126322002 @default.

• next